Translating Neurological Stem Cell Research into Therapies for Today’s Patients

Date

Tuesday, December 8, 2020
9:00 AM EST

Location

Webcast with Nature
Person watching Translating Neurological Stem Cell Research into Therapies for Today’s Patients webinar.

Overview

Neurological impairments are usually irreversible because of limited regeneration in the central nervous system. The regenerative capacity of stem cells makes them an attractive candidate for transplantation therapies, with many stem cells showing promise in basic research and preclinical trials.

This webcast -- a special 2-hour exploration of stem cells as a building block of regenerative therapy—will cover the cellular and molecular characteristics of embryonic stem cells, induced pluripotent stem cells, neural stem cells, and their in vivo and in vitro derivatives that could lay the foundation of future CNS regenerative therapies.

Learn about:

  • Producing reliable and robust stem cell derived neurons as building blocks for drug discovery
  • How advances in iPSC-derived organoid models recapitulate the “real” brain environment for CNS precision medicine
  • How engrafting various types of stem cells into animal models can predict translation to human patients

Register for the webcast

 

Webcast Presenters

Mark Kotter head shot

Mark Kotter
University of Cambridge and bit.bio


Thomas Hartung head shot

Thomas Hartung
Johns Hopkins Bloomberg School of Public Health


Kaisa Paldanius head shot

Kaisa Paldanius
Charles River